Loading.
Preparing your Shotlee experience
Preparing your Shotlee experience

Emerging research highlights the potential of alpha-ketoglutarate (AKG) in addressing insulin resistance and improving metabolic health. This blog post explores the science behind AKG and its potential benefits for longevity and overall wellness.
Insulin resistance is a growing concern, impacting millions worldwide. It's a key player in the development of type 2 diabetes, obesity, and other metabolic disorders. But what if there was a way to improve your body's response to insulin and unlock greater metabolic flexibility? Recent research points to the potential of alpha-ketoglutarate (AKG) as a powerful tool in this fight.
Insulin resistance occurs when your cells become less responsive to insulin, a hormone that helps glucose enter cells for energy. This forces your pancreas to produce more insulin to maintain normal blood sugar levels. Eventually, the pancreas can't keep up, leading to elevated blood sugar and a cascade of metabolic problems.
Metabolic inflexibility, closely linked to insulin resistance, refers to the body's inability to efficiently switch between using carbohydrates and fats for fuel. A healthy metabolism can seamlessly shift from burning carbs after a meal to burning fat during fasting. In metabolically inflexible individuals, this switch is impaired, often leading to a reliance on burning the wrong fuel at the wrong time.
According to a study in Nature Communications, ATM deficiency leads to systemic insulin resistance and metabolic inflexibility.
The study published in Nature Communications explored the impact of ATM (ataxia-telangiectasia mutated) deficiency on metabolic health. ATM is a protein kinase involved in DNA repair and cell cycle control.
Researchers found that mice with ATM deficiency developed insulin resistance and metabolic inflexibility. They were unable to efficiently use glucose for energy and showed signs of fat accumulation in the liver. This lead to a decline in overall health.
So, where does alpha-ketoglutarate (AKG) fit into this picture? AKG is a naturally occurring compound in the body that plays a vital role in various metabolic processes. It's a precursor to glutamate, an important neurotransmitter, and is involved in the Krebs cycle, the central pathway for energy production in cells.
The study also investigated the potential of AKG to mitigate these metabolic issues. The results were promising. AKG supplementation appeared to improve glucose metabolism, reduce insulin resistance, and enhance metabolic flexibility in ATM-deficient mice. This effect is likely due to AKG's role as a precursor to glutamate and its involvement in the Krebs cycle, supporting cellular energy production and metabolic balance.
Benefits of AKG May Include:
While the research on AKG is still evolving, there are several practical steps you can take to support your metabolic health right now:
Tools like Shotlee can help you track your diet, exercise, and other lifestyle factors that impact your metabolic health. Consistent tracking can provide valuable insights into your body's response to different interventions.
The research on AKG offers a glimpse into the exciting possibilities of targeted interventions for improving metabolic health and potentially extending lifespan. As we continue to unravel the complexities of metabolism, we can expect to see even more innovative strategies emerge for optimizing our health and well-being.
By understanding the underlying mechanisms of insulin resistance and metabolic inflexibility, and by exploring promising solutions like AKG, we can empower ourselves to take control of our health and build a foundation for a longer, healthier life.
⚠️ Disclaimer: This article is for informational purposes only. Consult your healthcare provider before starting any medication or supplement.
Original content from Nature
View Original Article
Bariatric surgery significantly impacts glucose and insulin responses. This post explores the nuances of these changes, focusing on the impact of different surgical procedures, sex-based differences, and the implications for personalized treatment of metabolic conditions.

Cipla and Eli Lilly are joining forces to expand access to tirzepatide, a GLP-1 receptor agonist, in India. This partnership aims to address the growing concerns of type 2 diabetes and obesity by distributing the drug under the brand name Yurpeak.
Monitor GLP-1 medications, peptide therapy, weight loss, and wellness metrics with our comprehensive health tracking app. Join thousands of users taking control of their health!
Start Tracking Free Forever! ✨